STAT+: Top Verily executives depart amid leadership shakeup and layoffs
Verily, a health technology company spun out of tech giant Alphabet, announced Wednesday that it…
Category: finance
STAT+: Medicare Advantage-focused Oak Street, Agilon Health chart out growth at J.P Morgan
Senior-focused primary care providers Oak Street Health and Agilon Health used their stage time at…
STAT+: Study finds heavier reliance on nurse practitioners, physician assistants after private equity takeovers
A new study suggests physician practices acquired by private equity rely more heavily on advanced…
STAT+: A flurry of pharma acquisitions kick off JPM week after a slow year for deals
SAN FRANCISCO — Within the first hours of the J.P. Morgan Healthcare Conference, four life…
STAT+: The health care providers and insurers we’re watching at JPM23 — and why
Hospitals, health insurers, and other provider-related companies are returning in person to the J.P. Morgan…
STAT+: Fate Therapeutics plans mass layoffs, after early end to cell therapy deal with Janssen
SAN DIEGO — Fate Therapeutics, a biotech upstart with big ambitions to use cell-based therapies…
STAT+: Providers seeking resolution of billing disputes under the No Surprises Act cause a major backlog of cases
Health care providers are swamping the government with billing disputes under the new law that…
STAT+: Get ready for ‘the electric vehicles of biopharma’: Three biotech trends to watch in 2023
Predicting the future is famously a mug’s game. Between Covid-19, drug pricing legislation, and a…
STAT+: Young private equity firm Catalio to absorb hedge fund HealthCor, capping off busy year of investment M&A
Two veterans of the health care investing world — Art Cohen and Joe Healey —…
STAT+: Biden admin shares ownership data for thousands of hospitals, improving transparency about private equity’s stake
Citing its commitment to transparency and promoting competition, the Biden administration on Tuesday released a…
STAT+: Nine in 10 health care companies with financial stress are owned by private equity
Almost 90% of the health care companies deemed to be under financial stress by a…
STAT+: The health insurer will see you now: How UnitedHealth is keeping more profits, as your doctor
Next year, UnitedHealth Group — one of the largest health care companies on the planet…
Opinion: Rushing into the World Bank’s Pandemic Fund is a bad idea
The World Bank has rolled out a new Financial Intermediary Fund for Pandemic Prevention, Preparedness,…
Opinion: The conundrum of biopharma investing: low rewards and high risks — but a big social benefit
Over the last decade, investors in biotech and pharmaceutical companies have been taking risks that…
STAT+: Hospital systems Sanford, Fairview plan to create $14 billion Midwest powerhouse
Two not-for-profit Midwest hospital systems are seeking to merge, creating what would be a health…
Amazon launches new health venture, Google tests search in health care, & Maven’s $90M round
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: With VillageMD investment, Cigna bets on value-based care for a younger, healthier crowd
These days, if you’re an insurer and you’re not buying into the health care provider…
STAT+: Boom and bust: Whose biotech VC assets have grown and shrunk the most?
Money has gushed into the biotech industry over the last couple of years, as the…
STAT+: Unexpected troubles hit large medical billing firm R1 RCM, part-owned by Ascension
The stock price of R1 RCM tanked by roughly 50% this week after the large…
STAT+: Unexpected troubles hit large medical billing firm R1 RCM, part-owned by Ascension
The stock price of R1 RCM tanked by roughly 50% this week after the large…
STAT+: Viatris executive is charged with insider trading scheme involving a friend and former colleague
A high-ranking Viatris executive was charged with insider trading for tipping a friend and former…
STAT+: Jeff Jonas leaves Sage Therapeutics to launch biotech incubator
Longtime Sage Therapeutics executive Jeff Jonas is leaving the biotech company to launch a biotech…
STAT+: Andreessen Horowitz partners with rural health system to give its companies a go-to pilot site
Innovative health tech startups with big ideas will not get very far if they cannot…
STAT+: Talkspace names a new CEO as its stock price continues to struggle
Following a year of executive shakeups and business rejiggering, Talkspace’s third quarter earnings came with…
Medicare’s midterm punts, MA marketing schemes, and a closer look at the Abiomed deal
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: Private equity’s Welsh Carson, casting itself as a noble force, relentlessly pursues profits in health care
Before the allegations of neglect, before the lawsuits, before the government investigations, the health care…
Opinion: Allocate opioid settlement dollars to real addiction-ending solutions
The crisis of opioid overdose deaths that sparked the multitude of lawsuits leading to a…
Biotech’s newest odd couple: A pharma insider and a music maven launch a health care VC
D.A. Wallach’s first meeting with his business partner could have been the setting of a…
STAT+: Josh Bilenker’s last biotech sold for $8 billion. His next one is cloaked in mystery but loaded with money
Josh Bilenker’s last company, Loxo Oncology, was purchased by Eli Lilly for $8 billion. No…
STAT+: The Q4 health tech tracker: 17 key industry events and milestones to watch
Health tech companies and their backers are increasingly cautious as they brace for uncertain market…
.jpg)
Get a Ph.D. in health policy — from a single Powerpoint slide
Looking for an actually concise explanation of a half-century’s worth of research and arguments about…
Bayer’s venture arm ramps up, seeking to invest $1.3 billion
Over the last six years, a venture capital team run out of pharmaceutical giant Bayer…
STAT+: Envision Healthcare teeters on the brink of bankruptcy
Envision Healthcare, the large chain of outpatient surgery centers and physician staffing services for hospitals,…
A teaching hospital payout, Humana flirts with Wall Street, and new dialysis incentives
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: Medical pioneers team up to launch new cell therapy biotech
Medical pioneers Carl June, Bruce Levine, and Drew Weissman have teamed up to launch a…
Raising a RUC-kus, Blues’ antitrust deal appealed, & a UAE deal
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: Once a small player among biotech VCs, Mubadala Capital Ventures is punching above its weight
At the start of 2021, blue-chip biotech investor ARCH Venture Partners and a relatively unknown…
STAT+: As medical device companies look to snap up Medicare dollars, potential conflicts lurk
Medicare is expected to pay more than $86 billion next year for care given in…
STAT+: OrbiMed tumbles from the top of STAT’s biotech venture capital performance ranking
Noted biotech investment firm OrbiMed slid from first place to 14th in STAT’s latest annual…
STAT+: Hospitals wrangle billions in FEMA funding to offset Covid costs
More hospitals are tapping into billions of dollars from the Federal Emergency Management Agency to…
STAT+: Ex-Google CEO’s VC firm brings in hype-busting researcher to expand its biotech investments
Innovation Endeavors, the venture capital firm co-founded by former Google chairman and CEO Eric Schmidt,…
STAT+: Hospital mergers that dodge antitrust scrutiny lead to dramatically higher prices, study finds
Hospitals that merge under state regulations that shield them from federal scrutiny tend to eventually…
STAT+: Bright Health Group heads toward insolvency as it rushes to raise more cash
A little more than a year after going public, Bright Health Group is in danger…
Private equity’s latest fixation & the ACA subsidy spigot
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: The private equity firms, like Blackstone and KKR, behind 8 of the biggest names in autism therapy
Private equity investors are backing all of the major chains offering the country’s most popular…
STAT+: One Medical’s dueling offers from Amazon and CVS signal a start to health tech bidding wars
It’s health tech hunting season for some of America’s biggest brand names. Over the last…
STAT+: Teladoc’s earnings point to potential threats to the telehealth industry
Telehealth giant Teladoc is bracing for disappointing earnings this year as it faces headwinds that…
STAT+: FDA’s decision to review a Biogen ALS drug is met with skepticism and uncertainty on Wall Street
Once again, the U.S. Food and Drug Administration made a surprise move regarding an experimental…
STAT+: American Cancer Society’s VC arm partners with Third Rock on oncology companies
Cancer startups aren’t exactly underfunded — as a disease area, oncology has commanded investors’ attention…
Patients’ new credit card crunch, Amazon’s getting serious, and inflation has entered the chat
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow…